Jump Financial, LLC Adverum Biotechnologies, Inc. Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.74 - $2.4 $46,284 - $63,840	-26,600 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.08 - $3.6 $29,872 - $51,703	14,362 Added 117.36%	26,600 $58,000
Q2 2021 Aug 13, 2021	SELL	$3.36 - $10.56 $102,752 - $322,935	-30,581 Reduced 71.42%	12,238 $43,000
Q1 2021 May 17, 2021	BUY	$9.26 - $14.36 $151,113 - $234,340	16,319 Added 61.58%	42,819 $422,000
Q4 2020 Feb 12, 2021	SELL	$9.84 - $14.26 $154,674 - $224,152	-15,719 Reduced 37.23%	26,500 $287,000
Q3 2020 Nov 13, 2020	BUY	$10.3 - $21.64 $434,855 - $913,619	42,219 New	42,219 $434,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.